Nyxoah SA Cash on Hand 2021-2024 | NYXH
Nyxoah SA cash on hand from 2021 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Nyxoah SA Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $63 |
| 2022 | $100 |
| 2021 | $160 |
| 2020 | $105 |
| Nyxoah SA Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-03-31 | $48 |
| 2023-12-31 | $63 |
| 2023-09-30 | $79 |
| 2023-06-30 | $92 |
| 2023-03-31 | $103 |
| 2022-12-31 | $100 |
| 2022-09-30 | $116 |
| 2022-06-30 | $131 |
| 2022-03-31 | $143 |
| 2021-12-31 | |
| 2021-03-31 | $104 |
| 2020-12-31 | $105 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.257B | 19.36 |
| Tempus AI (TEM) | United States | $5.669B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.401B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.980B | 0.00 |
| Axonics (AXNX) | United States | $3.445B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $3.202B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.010B | 0.00 |
| Azenta (AZTA) | United States | $2.800B | 157.42 |
| Enovis (ENOV) | United States | $2.438B | 18.07 |
| 10x Genomics (TXG) | United States | $2.234B | 0.00 |
| Privia Health (PRVA) | United States | $2.022B | 113.00 |
| Schrodinger (SDGR) | United States | $1.461B | 0.00 |
| Omnicell (OMCL) | United States | $1.229B | 42.48 |
| Phreesia (PHR) | United States | $1.177B | 0.00 |
| Standard BioTools (LAB) | United States | $0.682B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.621B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.365B | 0.00 |
| Talkspace (TALK) | United States | $0.365B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| Pulmonx (LUNG) | United States | $0.245B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.209B | 0.00 |
| Outset Medical (OM) | United States | $0.199B | 0.00 |
| TruBridge (TBRG) | United States | $0.168B | 9.02 |
| P3 Health Partners (PIII) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.089B | 0.00 |
| 111 (YI) | China | $0.088B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.080B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.071B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.049B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.048B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| CareCloud (CCLD) | United States | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Biotricity (BTCY) | United States | $0.007B | 0.00 |
| Transgenomic (PRPO) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |